J B Chemicals & Pharmaceuticals Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
27865.25 Cr.
|
P/BV
|
8.67
|
Book Value (Rs.)
|
205.50
|
52 Week High/Low (Rs.)
|
2030/1386
|
FV/ML
|
1/1
|
P/E(X)
|
42.25
|
Bookclosure
|
30/07/2025
|
EPS (Rs.)
|
42.19
|
Div Yield (%)
|
0.87
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 |
No. of Equity Shares (in Lacs) | 1556.77 | 1551.95 | 773.78 | 772.82 | 772.82 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 15.57 | 15.52 | 15.48 | 15.46 | 15.46 |
Total Share Capital | 15.57 | 15.52 | 15.48 | 15.46 | 15.46 |
| | | | | |
Reserves and Surplus | 3417.75 | 2907.81 | 2343.26 | 2056.01 | 1794.27 |
Total Reserves and Surplus | 3417.75 | 2907.81 | 2343.26 | 2056.01 | 1794.27 |
Employees Stock Options | 0.00 | 0.00 | 121.59 | 62.65 | 0.00 |
Total Shareholders Funds | 3433.32 | 2923.33 | 2480.33 | 2134.12 | 1809.72 |
Equity Share Application Money | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 4.49 | 3.71 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 0.00 | 23.64 | 383.22 | 0.00 | 0.00 |
Deferred Tax Liabilities [Net] | 177.34 | 149.21 | 102.82 | 47.56 | 56.77 |
Other Long Term Liabilities | 8.25 | 11.34 | 17.81 | 23.78 | 10.07 |
Long Term Provisions | 22.53 | 18.39 | 15.21 | 13.73 | 12.57 |
Total Non-Current Liabilities | 208.13 | 202.57 | 519.07 | 85.07 | 79.41 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 13.80 | 333.50 | 165.02 | 26.32 | 32.64 |
Trade Payables | 410.72 | 356.31 | 238.65 | 224.48 | 186.92 |
Other Current Liabilities | 145.56 | 129.35 | 108.28 | 87.40 | 97.73 |
Short Term Provisions | 62.26 | 49.06 | 42.50 | 45.52 | 27.98 |
Total Current Liabilities | 632.34 | 868.23 | 554.45 | 383.72 | 345.27 |
| | | | | |
Total Capital And Liabilities | 4273.78 | 3994.13 | 3553.87 | 2607.40 | 2238.12 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 609.94 | 571.56 | 532.01 | 552.91 | 544.09 |
Intangible Assets | 1300.79 | 1375.38 | 1311.54 | 666.63 | 32.11 |
Capital Work-In-Progress | 46.70 | 63.32 | 44.41 | 13.91 | 25.57 |
Intangible Assets Under Development | 16.35 | 13.08 | 10.74 | 4.77 | 0.00 |
Fixed Assets | 1973.78 | 2023.34 | 1898.70 | 1238.21 | 601.76 |
Goodwill On Consolidation | 57.46 | 57.46 | 57.46 | 57.46 | 57.46 |
Non-Current Investments | 27.98 | 23.71 | 13.78 | 12.72 | 12.91 |
Deferred Tax Assets [Net] | 8.42 | 5.88 | 6.51 | 6.43 | 6.94 |
Long Term Loans And Advances | 0.35 | 0.58 | 0.68 | 0.74 | 5.19 |
Other Non-Current Assets | 283.04 | 29.82 | 48.70 | 16.98 | 1.25 |
Total Non-Current Assets | 2351.04 | 2140.78 | 2025.84 | 1332.55 | 685.51 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Current Investments | 317.11 | 364.65 | 192.18 | 0.00 | 664.97 |
Inventories | 528.96 | 502.51 | 430.48 | 409.96 | 347.45 |
Trade Receivables | 815.38 | 686.92 | 575.80 | 555.69 | 389.02 |
Cash And Cash Equivalents | 129.45 | 95.54 | 78.81 | 58.53 | 30.85 |
Short Term Loans And Advances | 0.55 | 0.70 | 1.37 | 1.30 | 1.93 |
OtherCurrentAssets | 131.30 | 203.03 | 249.38 | 249.38 | 118.38 |
Total Current Assets | 1922.74 | 1853.35 | 1528.03 | 1274.86 | 1552.60 |
| | | | | |
Total Assets | 4273.78 | 3994.13 | 3553.87 | 2607.40 | 2238.12 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 1165.42 | 1110.90 | 148.86 | 68.13 | 121.03 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 8.46 | 8.46 | 8.46 | 8.46 | 8.46 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Unquoted Book Value | 27.98 | 23.71 | 13.78 | 12.72 | 12.91 |
| | | | | |
CURRENT INVESTMENTS | | | | | |
Current Investments Quoted Market Value | 317.11 | 364.65 | 0.00 | 0.00 | 664.97 |